BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 7285619)

  • 1. Two-dimensional echocardiography in acquired heart diseases--Part I.
    Giuliani ER; Nasser FN
    Curr Probl Cardiol; 1981 Feb; 5(11):1-47. PubMed ID: 7285619
    [No Abstract]   [Full Text] [Related]  

  • 2. Cardiac sound and ultrasound: echocardiographic and phonocardiographic correlations--Part II.
    Ronan JA
    Curr Probl Cardiol; 1981 Sep; 6(6):1-58. PubMed ID: 7197610
    [No Abstract]   [Full Text] [Related]  

  • 3. [Echocardiography. Part II--Valve dysfunctions].
    Matsumoto AY; Barbato AJ; Kaiser E; Lima EV; Savioli RM; Ortiz J; Del Nero E
    Arq Bras Cardiol; 1979 Sep; 33(3):217-23. PubMed ID: 543811
    [No Abstract]   [Full Text] [Related]  

  • 4. [Auscultation and phonocardiography in acquired heart defects].
    Michel D
    Internist (Berl); 1965 Dec; 6(12):515-29. PubMed ID: 5334459
    [No Abstract]   [Full Text] [Related]  

  • 5. Echocardiography in valvular heart disease.
    Teichholz LE
    Prog Cardiovasc Dis; 1975; 17(4):283-302. PubMed ID: 1089993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitral valve disease revisited.
    DeMaria AN; Neumann A; Lee G; Mason DT
    Cardiovasc Clin; 1978; 9(2):59-84. PubMed ID: 359156
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical uses of two dimensional echocardiography.
    Kotler MN; Mintz GS; Segal BL; Parry WR
    Am J Cardiol; 1980 May; 45(5):1061-82. PubMed ID: 6989225
    [No Abstract]   [Full Text] [Related]  

  • 8. Newer noninvasive methods in pediatric cardiology: echocardiography, isotope angiography.
    Silverman NH
    Adv Pediatr; 1976; 23():357-99. PubMed ID: 795283
    [No Abstract]   [Full Text] [Related]  

  • 9. [2-dimensional echocardiography in acquired heart valve defects].
    Schweizer P; Erbel R; Lambertz H; Effert S
    Ultraschall Med; 1983 Dec; 4(4):204-12. PubMed ID: 6669980
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnosis and assessment of valve stenosis and regurgitation and coarctation of the aorta with Doppler ultrasound.
    Hatle L
    Acta Paediatr Scand Suppl; 1986; 329():10-20. PubMed ID: 3473895
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Echocardiography].
    Tomov I; Todorova M
    Vutr Boles; 1974; 13(6):7-19. PubMed ID: 4619518
    [No Abstract]   [Full Text] [Related]  

  • 12. Non-invasive methods are reliable for quantification of valvular stenoses and regurgitation.
    Burckhardt D; Amann FW; Hoffmann A
    Z Kardiol; 1986; 75 Suppl 2():1-12. PubMed ID: 2941925
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical aspects of acquired valvular heart disease.
    Fowler NO
    Semin Roentgenol; 1979 Apr; 14(2):83-95. PubMed ID: 462200
    [No Abstract]   [Full Text] [Related]  

  • 14. Doppler echocardiography. The localization of cardiac murmurs.
    Johnson SL; Baker DW; Lute RA; Dodge HT
    Circulation; 1973 Oct; 48(4):810-22. PubMed ID: 4744787
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical aspects of rheumatic valvular disease.
    Reichek N; Shelburne JC; Perloff JK
    Prog Cardiovasc Dis; 1973; 15(5):491-537. PubMed ID: 4571260
    [No Abstract]   [Full Text] [Related]  

  • 16. [Which patients with heart valve diseases require invasive evaluation?].
    Ugartemendia C; Esplugas E
    Rev Esp Cardiol; 1995 Apr; 48(4):215-22. PubMed ID: 7740141
    [No Abstract]   [Full Text] [Related]  

  • 17. Doppler echocardiography in the evaluation of valvular heart disease.
    Missri JC
    Can J Cardiol; 1986; 2(1):16-23. PubMed ID: 3633748
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Silent valvular heart disease.
    Harvey WP
    Cardiovasc Clin; 1973; 5(2):77-95. PubMed ID: 4780194
    [No Abstract]   [Full Text] [Related]  

  • 19. Usefulness of echo-Doppler in management of patients with valvular heart disease.
    Bansal RC; Shah PM
    Curr Probl Cardiol; 1989 Jun; 14(6):281-350. PubMed ID: 2663379
    [No Abstract]   [Full Text] [Related]  

  • 20. 26th Bethesda conference: recommendations for determining eligibility for competition in athletes with cardiovascular abnormalities. Task Force 2: acquired valvular heart disease.
    Cheitlin MD; Douglas PS; Parmley WW
    Med Sci Sports Exerc; 1994 Oct; 26(10 Suppl):S254-60. PubMed ID: 7934748
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.